Company intelligence / Profile preview

Junaxo Inc.

Toronto, Ontario, Canadaatuka.com ↗

Ownership: Private
Employees: ~3
Development stage: Preclinical

Overview

Junaxo Inc. develops drug candidates by repurposing compounds with established human safety profiles as new treatments for Parkinson’s disease and other neurodegenerative disorders. The company has three clinical trial-ready compounds but no published clinical results yet.[1][2]

Therapeutic areas: Neurology
Modalities: Small molecules (repurposed compounds with proven human safety)[2]
Industry: Biotech

Beyond the preview

Go deeper on Junaxo Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Junaxo Inc..

Explore the full profile